Aciraz Tablets
Systematic (IUPAC) name | |
---|---|
(RS)-2-([4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole |
Rabeprazole Sodium eq. to
Rabeprazole 20 mg
Rabeprozole is indicated for the treatment of active duodenal ulcer. Symptomatic erosive or ulcerative gastrooesophageal reflux disease (GERD). H.Pylori-positive duodenal ulcers, as part of the eradication programme with
appropriate antibiotics, maintenance treatment of healed erosive or ulcerative GERD. Efficacy has not been demonstrated
for periods exceeding 12 months.
Composition
Each Enteric coated tablet contains
Rabeprazole Sodium eq to Rabeprazole 20mg
Dosage ( For dosage consult Doctor)**
The recommended adult oral dose is one tablet to be taken once daily for four to eight weeks.
Indications
ACIRAZ is indicated for the relief of symptoms of
Dyspepsia
GERD
Nausea associated with acid peptic disorders
Post-operative nausea and
vomit
Chronic gastritis
Restriction of usage ( ref from
- acute hepatic failure
- pediatric use in patients under 18 years of age (there are insufficient data about safety and efficiency of rabeprazole in this group of patients)
No comments:
Post a Comment